Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03700606 · ClinicalTrials.gov registry record · NA
Physiological Changes With High-Flow Nasal Cannula
A NA study, sponsored by Sharp HealthCare.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT03700606: Completed NA study, sponsored by Sharp HealthCare.
NCT03700606 is a NA study that has completed, run by Sharp HealthCare. The registered enrollment target is 80 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03700606, a NA study, has completed, sponsored by Sharp HealthCare.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
To measure changes in physiologic parameters in extremely low birthweight (ELBW) infants on high-flow nasal cannula compared to nasal continuous positive airway pressure (nCPAP).
Interventions
- PROCEDURE High flow nasal cannula
- PROCEDURE Nasal CPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2019-03-15 |
| Est. Completion | 2022-02-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03700606
The ClinicalTrials.gov registry entry for NCT03700606 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sharp HealthCare, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which High flow nasal cannula is the first listed.
NCT03700606 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03700606 about?
NCT03700606 is a clinical study titled "Physiological Changes With High-Flow Nasal Cannula". To measure changes in physiologic parameters in extremely low birthweight (ELBW) infants on high-flow nasal cannula compared to nasal continuous positive airway pressure (nCPAP).
What is the current status of trial NCT03700606?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2019-03-15. Estimated completion is 2022-02-14.
What interventions are being tested in trial NCT03700606?
The interventions under investigation include: High flow nasal cannula (PROCEDURE), Nasal CPAP (PROCEDURE).
Who is sponsoring clinical trial NCT03700606?
This trial is sponsored by Sharp HealthCare, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.